Dawn Sauro has more than 30 years of drug and device development experience. She most recently served as the Chief Growth Officer at WCG Clinical, responsible for the company’s enterprise growth and commercialization strategy.  Prior to WCG, she was Elligo Health Research’s COO where she furthered the company’s growth, efficiency and mission of optimizing the intersection of healthcare and research.  Dawn also served as the Chief Development Officer at Clinipace (now Caidya) where she developed the strategy and grew the organization to be a trusted partner for sponsors.  Prior roles include President, Development Innovations at Sarah Cannon, and SVP & General Manager Hematology and Oncology at inVentiv Health (now Syneos).